Eptotermin alfa

DB11631ApprovedWithdrawnProtein Based Therapies

A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in...

Mechanism: Pharmacologically active on Activin receptor type-1, Bone morphogenetic protein receptor type-1A, and Bone morphogenetic protein receptor type-2
Curator reviewed
Also known as: BMP-7 · Bone morphogenetic protein 7 · HBMP7 · HrBMP-7 · Human recombinant bone morphogenetic protein 7

Resolves to

Compound

UNIIIT063R5MY0CAS129805-33-0ChEMBLCHEMBL2108594

Clinical / RWD

ATCM05BC02

Targets

Q04771ACVR1P36894BMPR1AQ13873BMPR2O00238BMPR1B

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

6Marketed productsAcross 2 countries and 1 labeller

1ATC codeIncluding every combination product, plus 10 drug categories

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Eptotermin alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account